Sodium channel molecular conformations and antiarrhythmic drug affinity.
Sodium channel molecular conformations and antiarrhythmic drug affinity.
复制标题
DOI:
10.1016/j.tcm.2010.03.002
复制
发表时间:
2010-01
影响因子:
9.3
通讯作者:
Hanck, Dorothy A.
中科院分区:
文献类型:
--
作者:
Sheets, Michael F.;Fozzard, Harry A.;Lipkind, Gregory M.;Hanck, Dorothy A.
Class I cardiac antiarrhythmic drugs, e.g. lidocaine, mexiletine, flecainide, quinidine, and procainamide, continue to play an important role in the therapy of cardiac arrhythmias because of the presence of use-dependent block. Lidocaine, as well as related drugs like mepivacaine, bupivacaine, and cocaine, also belong to the class of medications referred to as local anesthetics. In this review we will consider lidocaine as the prototypical antiarrhythmic drug because it continues to be widely used both as an antiarrhythmic drug (first used as an antiarrhythmic drug in 1950) as well as a local anesthetic agent. Both of these clinical uses depend upon block of sodium current (INa), but it is the presence of use-dependent INa block, i.e. an increasing amount of block at faster heart rates, that allows a local anesthetic agent to be a useful antiarrhythmic drug. Although many early studies investigated the action of antiarrhythmic drugs on Na currents, the availability of site-directed mutant Na channels has allowed for major advances in understanding their mechanisms of action based upon molecular conformations of the Na channel.
登录
查看更多内容
影响因子:
3.6
作者:
Nau, C;Wang, SY;Wang, GK
通讯作者:
Wang, GK
影响因子:
3.8
作者:
Kitaguchi, Tetsuya;Sukhareva, Manana;Swartz, Kenton J
通讯作者:
Swartz, Kenton J
影响因子:
16.8
作者:
通讯作者:
--
影响因子:
37.8
作者:
Rudy Y;Ackerman MJ;Bers DM;Clancy CE;Houser SR;London B;McCulloch AD;Przywara DA;Rasmusson RL;Solaro RJ;Trayanova NA;Van Wagoner DR;Varró A;Weiss JN;Lathrop DA
通讯作者:
Lathrop DA
影响因子:
56.9
作者:
Long, SB;Campbell, EB;MacKinnon, R
通讯作者:
MacKinnon, R